STEPHANIE HENNING

HR 4279 (Pro-IP Act) Global intellectual property rights protection (no bills) International pharmaceutical market access (no bills) WTO accession and implementation issues (no bills) US-Korea Free Trade Agreement (no bills) US-Peru Free Trade Agreement (no bills) US-Columbia Free Trade Agreement (no bills) US-Panama Free Trade Agreement (no bills) Norway Patent issues (no bills) Poland market access (no bills) Russia permanent normal trade relations (no bills) Turkey Market Access (no bills) Free Trade Agreement Implementation Legislation (Peru, Columbia, Panama, Korea, Israel, Saudi Arabia) OECD Accession Saudi Arabia Patent Issues (no bills) South Africa Pricing & Patent Issues (no bills) Israel Patent Issues (no bills) Czech Republic Market Access Finland Patent Issues

HR 4279 (Pro-IP Act) Global intellectual property rights protection (no bills) International pharmaceutical market access (no bills) WTO accession and implementation issues (no bills) US-Korea Free Trade Agreement (no bills) US-Peru Free Trade Agreement (no bills) US-Columbia Free Trade Agreement (no bills) US-Panama Free Trade Agreement (no bills) Norway Patent issues (no bills) Poland market access (no bills) Russia permanent normal trade relations (no bills) Turkey Market Access (no bills) Free Trade Agreement Implementation Legislation (Peru, Columbia, Panama, Korea, Israel, Saudi Arabia) OECD Accession Saudi Arabia Patent Issues (no bills) South Africa Pricing & Patent Issues (no bills) Israel Patent Issues (no bills) Czech Republic Market Access Finland Patent Issues

Global intellectual property rights protection (no bills) International pharmaceutical market access (no bills) WTO accession and implementation issues (no bills) HR 4279 (Pro-IP Act) US-Korea Free Trade Agreement (no bills) US-Peru Free Trade Agreement (no bills) US-Columbia Free Trade Agreement (no bills) US-Panama Free Trade Agreement (no bills) Norway Patent issues (no bills) Poland market access (no bills) Russia permanent normal trade relations (no bills) Turkey Market Access (no bills) Free Trade Agreement Implementation Legislation (Peru, Columbia, Panama, Korea, Israel, Saudi Arabia) OECD Accession

HR 4279 (Pro-IP Act) Global intellectual property rights protection (no bills) International pharmaceutical market access (no bills) WTO accession and implementation issues (no bills) US-Korea Free Trade Agreement (no bills) US-Peru Free Trade Agreement (no bills) US-Columbia Free Trade Agreement (no bills) US-Panama Free Trade Agreement (no bills) Norway Patent issues (no bills) Poland market access (no bills) Russia permanent normal trade relations (no bills) Turkey Market Access (no bills) Free Trade Agreement Implementation Legislation (Peru, Columbia, Panama, Korea, Israel, Saudi Arabia) OECD Accession

HR. 1432, Preserve Access to Affordable Generics Act (settlements) 3/07 S. 316, Preserve Access to Affordable Generics Act (settlements) 3/07 S. 445, Patent Reform Act HR 1908, Patent Reform Act S 2300, Lower PRICED Drugs Act, legislation pediatric exclusivity, citizens petitions HR 6022, Lower PRICED Drugs Act, legislation on pediatric exclusivity, citizens petitions S 3695, To Amend the Federal Food, Drug & Cosmetic Act to prohibit the marketing of authorized generic drugs, authorized generics HR 5993, To amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs HR 5120, To Amend Title 35, United States Code, to confirm certain filing provisions within the Patent and Trademark Office. HR 5418, To establish a pilot program in certain United States district courts to encourage enhancement of expertise in patent cases among district judges S 438, Fair Prescription Drug Competition Act (ban authorized generics) 1/07 HR 780, Counterfeit Drug Prevention Act of 2007 3/07 HR 1908, Patent Reform Act of 2007 S 1145, Patent Reform Act of 2007 S 623, Access to Life-Saving Medication Act (FOBS) 2/07 HR 1038, Access to Life-Saving Medication Act HR 5629, Pathway For Biosimilars Act

HR. 1432, Preserve Access to Affordable Generics Act (settlements) 3/07 S. 316, Preserve Access to Affordable Generics Act (settlements) 3/07 S. 445, Patent Reform Act HR 1908, Patent Reform Act S 2300, Lower PRICED Drugs Act, legislation pediatric exclusivity, citizens petitions HR 6022, Lower PRICED Drugs Act, legislation on pediatric exclusivity, citizens petitions S 3695, To Amend the Federal Food, Drug & Cosmetic Act to prohibit the marketing of authorized generic drugs, authorized generics HR 5993, To amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs HR 5120, To Amend Title 35, United States Code, to confirm certain filing provisions within the Patent and Trademark Office. HR 5418, To establish a pilot program in certain United States district courts to encourage enhancement of expertise in patent cases among district judges S 438, Fair Prescription Drug Competition Act (ban authorized generics) 1/07 HR 780, Counterfeit Drug Prevention Act of 2007 3/07 HR 1908, Patent Reform Act of 2007 S 1145, Patent Reform Act of 2007 S 623, Access to Life-Saving Medication Act (FOBS) 2/07 HR 1038, Access to Life-Saving Medication Act HR 5629, Pathway For Biosimilars Act

HR. 1432, Preserve Access to Affordable Generics Act (settlements) 3/07 S. 316, Preserve Access to Affordable Generics Act (settlements) 3/07 S. 445, Patent Reform Act HR 1908, Patent Reform Act S 2300, Lower PRICED Drugs Act, legislation pediatric exclusivity, citizens petitions HR 6022, Lower PRICED Drugs Act, legislation on pediatric exclusivity, citizens petitions S 3695, To Amend the Federal Food, Drug & Cosmetic Act to prohibit the marketing of authorized generic drugs, authorized generics HR 5993, To amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs HR 5120, To Amend Title 35, United States Code, to confirm certain filing provisions within the Patent and Trademark Office. HR 5418, To establish a pilot program in certain United States district courts to encourage enhancement of expertise in patent cases among district judges S 438, Fair Prescription Drug Competition Act (ban authorized generics) 1/07 HR 780, Counterfeit Drug Prevention Act of 2007 3/07 HR 1908, Patent Reform Act of 2007 S 1145, Patent Reform Act of 2007 S 623, Access to Life-Saving Medication Act (FOBS) 2/07 HR 1038, Access to Life-Saving Medication Act HR 5629, Pathway For Biosimilars Act

HR. 1432, Preserve Access to Affordable Generics Act (settlements) 3/07 S. 316, Preserve Access to Affordable Generics Act (settlements) 3/07 S. 445, Patent Reform Act HR 1908, Patent Reform Act S 2300, Lower PRICED Drugs Act, legislation pediatric exclusivity, citizens petitions HR 6022, Lower PRICED Drugs Act, legislation on pediatric exclusivity, citizens petitions S 3695, To Amend the Federal Food, Drug & Cosmetic Act to prohibit the marketing of authorized generic drugs, authorized generics HR 5993, To amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs HR 5120, To Amend Title 35, United States Code, to confirm certain filing provisions within the Patent and Trademark Office. HR 5418, To establish a pilot program in certain United States district courts to encourage enhancement of expertise in patent cases among district judges S 438, Fair Prescription Drug Competition Act (ban authorized generics) 1/07 HR 780, Counterfeit Drug Prevention Act of 2007 3/07 HR 1908, Patent Reform Act of 2007 S 1145, Patent Reform Act of 2007 S 623, Access to Life-Saving Medication Act (FOBS) 2/07 HR 1038, Access to Life-Saving Medication Act HR 5629, Pathway For Biosimilars Act

HR. 1432, Preserve Access to Affordable Generics Act (settlements) 3/07 S. 316, Preserve Access to Affordable Generics Act (settlements) 3/07 S. 445, Patent Reform Act HR 1908, Patent Reform Act S 2300, Lower PRICED Drugs Act, legislation pediatric exclusivity, citizens petitions HR 6022, Lower PRICED Drugs Act, legislation on pediatric exclusivity, citizens petitions S 3695, To Amend the Federal Food, Drug & Cosmetic Act to prohibit the marketing of authorized generic drugs, authorized generics HR 5993, To amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs HR 5120, To Amend Title 35, United States Code, to confirm certain filing provisions within the Patent and Trademark Office. HR 5418, To establish a pilot program in certain United States district courts to encourage enhancement of expertise in patent cases among district judges S 438, Fair Prescription Drug Competition Act (ban authorized generics) 1/07 HR 780, Counterfeit Drug Prevention Act of 2007 3/07 HR 1908, Patent Reform Act of 2007 S 1145, Patent Reform Act of 2007 S 623, Access to Life-Saving Medication Act (FOBS) 2/07 HR 1038, Access to Life-Saving Medication Act HR 5629, Pathway For Biosimilars Act

HR. 1432, Preserve Access to Affordable Generics Act (settlements) 3/07 S. 316, Preserve Access to Affordable Generics Act (settlements) 3/07 S. 445, Patent Reform Act HR 1908, Patent Reform Act S 2300, Lower PRICED Drugs Act, legislation pediatric exclusivity, citizens petitions HR 6022, Lower PRICED Drugs Act, legislation on pediatric exclusivity, citizens petitions S 3695, To Amend the Federal Food, Drug & Cosmetic Act to prohibit the marketing of authorized generic drugs, authorized generics HR 5993, To amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs HR 5120, To Amend Title 35, United States Code, to confirm certain filing provisions within the Patent and Trademark Office. HR 5418, To establish a pilot program in certain United States district courts to encourage enhancement of expertise in patent cases among district judges S 438, Fair Prescription Drug Competition Act (ban authorized generics) 1/07 HR 780, Counterfeit Drug Prevention Act of 2007 3/07 HR 1908, Patent Reform Act of 2007 S 1145, Patent Reform Act of 2007 S 623, Access to Life-Saving Medication Act (FOBS) 2/07 HR 1038, Access to Life-Saving Medication Act HR 5629, Pathway For Biosimilars Act

HR. 1432, Preserve Access to Affordable Generics Act (settlements) 3/07 S. 316, Preserve Access to Affordable Generics Act (settlements) 3/07 S. 445, Patent Reform Act HR 1908, Patent Reform Act S 2300, Lower PRICED Drugs Act, legislation pediatric exclusivity, citizens petitions HR 6022, Lower PRICED Drugs Act, legislation on pediatric exclusivity, citizens petitions S 3695, To Amend the Federal Food, Drug & Cosmetic Act to prohibit the marketing of authorized generic drugs, authorized generics HR 5993, To amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs HR 5120, To Amend Title 35, United States Code, to confirm certain filing provisions within the Patent and Trademark Office. HR 5418, To establish a pilot program in certain United States district courts to encourage enhancement of expertise in patent cases among district judges S 438, Fair Prescription Drug Competition Act (ban authorized generics) 1/07 HR 780, Counterfeit Drug Prevention Act of 2007 3/07 HR 1908, Patent Reform Act of 2007 S 1145, Patent Reform Act of 2007 S 623, Access to Life-Saving Medication Act (FOBS) 2/07 HR 1038, Access to Life-Saving Medication Act HR 5629, Pathway For Biosimilars Act

HR. 1432, Preserve Access to Affordable Generics Act (settlements) 3/07 S. 316, Preserve Access to Affordable Generics Act (settlements) 3/07 S. 445, Patent Reform Act HR 1908, Patent Reform Act S 2300, Lower PRICED Drugs Act, legislation pediatric exclusivity, citizens petitions HR 6022, Lower PRICED Drugs Act, legislation on pediatric exclusivity, citizens petitions S 3695, To Amend the Federal Food, Drug & Cosmetic Act to prohibit the marketing of authorized generic drugs, authorized generics HR 5993, To amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs HR 5120, To Amend Title 35, United States Code, to confirm certain filing provisions within the Patent and Trademark Office. HR 5418, To establish a pilot program in certain United States district courts to encourage enhancement of expertise in patent cases among district judges S 438, Fair Prescription Drug Competition Act (ban authorized generics) 1/07 HR 780, Counterfeit Drug Prevention Act of 2007 3/07 HR 1908, Patent Reform Act of 2007 S 1145, Patent Reform Act of 2007 S 623, Access to Life-Saving Medication Act (FOBS) 2/07 HR 1038, Access to Life-Saving Medication Act HR 5629, Pathway For Biosimilars Act

HR. 1432, Preserve Access to Affordable Generics Act (settlements) 3/07 S. 316, Preserve Access to Affordable Generics Act (settlements) 3/07 S. 445, Patent Reform Act HR 1908, Patent Reform Act S 2300, Lower PRICED Drugs Act, legislation pediatric exclusivity, citizens petitions HR 6022, Lower PRICED Drugs Act, legislation on pediatric exclusivity, citizens petitions S 3695, To Amend the Federal Food, Drug & Cosmetic Act to prohibit the marketing of authorized generic drugs, authorized generics HR 5993, To amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs HR 5120, To Amend Title 35, United States Code, to confirm certain filing provisions within the Patent and Trademark Office. HR 5418, To establish a pilot program in certain United States district courts to encourage enhancement of expertise in patent cases among district judges S 438, Fair Prescription Drug Competition Act (ban authorized generics) 1/07 HR 780, Counterfeit Drug Prevention Act of 2007 3/07 HR 1908, Patent Reform Act of 2007 S 1145, Patent Reform Act of 2007 S 623, Access to Life-Saving Medication Act (FOBS) 2/07 HR 1038, Access to Life-Saving Medication Act HR 5629, Pathway For Biosimilars Act

HR. 1432, Preserve Access to Affordable Generics Act (settlements) 3/07 S. 316, Preserve Access to Affordable Generics Act (settlements) 3/07 S. 445, Patent Reform Act HR 1908, Patent Reform Act S 2300, Lower PRICED Drugs Act, legislation pediatric exclusivity, citizens petitions HR 6022, Lower PRICED Drugs Act, legislation on pediatric exclusivity, citizens petitions S 3695, To Amend the Federal Food, Drug & Cosmetic Act to prohibit the marketing of authorized generic drugs, authorized generics HR 5993, To amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs HR 5120, To Amend Title 35, United States Code, to confirm certain filing provisions within the Patent and Trademark Office. HR 5418, To establish a pilot program in certain United States district courts to encourage enhancement of expertise in patent cases among district judges S 438, Fair Prescription Drug Competition Act (ban authorized generics) 1/07 HR 780, Counterfeit Drug Prevention Act of 2007 3/07 HR 1908, Patent Reform Act of 2007 S 1145, Patent Reform Act of 2007 S 623, Access to Life-Saving Medication Act (FOBS) 2/07 HR 1038, Access to Life-Saving Medication Act HR 5629, Pathway For Biosimilars Act

HR. 1432, Preserve Access to Affordable Generics Act (settlements) 3/07 S. 316, Preserve Access to Affordable Generics Act (settlements) 3/07 S. 445, Patent Reform Act HR 1908, Patent Reform Act S 2300, Lower PRICED Drugs Act, legislation pediatric exclusivity, citizens petitions HR 6022, Lower PRICED Drugs Act, legislation on pediatric exclusivity, citizens petitions S 3695, To Amend the Federal Food, Drug & Cosmetic Act to prohibit the marketing of authorized generic drugs, authorized generics HR 5993, To amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs HR 5120, To Amend Title 35, United States Code, to confirm certain filing provisions within the Patent and Trademark Office. HR 5418, To establish a pilot program in certain United States district courts to encourage enhancement of expertise in patent cases among district judges S 438, Fair Prescription Drug Competition Act (ban authorized generics) 1/07 HR 780, Counterfeit Drug Prevention Act of 2007 3/07 HR 1908, Patent Reform Act of 2007 S 1145, Patent Reform Act of 2007 S 623, Access to Life-Saving Medication Act (FOBS) 2/07 HR 1038, Access to Life-Saving Medication Act HR 5629, Pathway For Biosimilars Act

HR. 1432, Preserve Access to Affordable Generics Act (settlements) 3/07 S. 316, Preserve Access to Affordable Generics Act (settlements) 3/07 S. 445, Patent Reform Act HR 1908, Patent Reform Act S 2300, Lower PRICED Drugs Act, legislation pediatric exclusivity, citizens petitions HR 6022, Lower PRICED Drugs Act, legislation on pediatric exclusivity, citizens petitions S 3695, To Amend the Federal Food, Drug & Cosmetic Act to prohibit the marketing of authorized generic drugs, authorized generics HR 5993, To amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs HR 5120, To Amend Title 35, United States Code, to confirm certain filing provisions within the Patent and Trademark Office. HR 5418, To establish a pilot program in certain United States district courts to encourage enhancement of expertise in patent cases among district judges S 438, Fair Prescription Drug Competition Act (ban authorized generics) 1/07 HR 780, Counterfeit Drug Prevention Act of 2007 3/07 HR 1908, Patent Reform Act of 2007 S 1145, Patent Reform Act of 2007 S 623, Access to Life-Saving Medication Act (FOBS) 2/07 HR 1038, Access to Life-Saving Medication Act HR 5629, Pathway For Biosimilars Act

HR. 1432, Preserve Access to Affordable Generics Act (settlements) 3/07 S. 316, Preserve Access to Affordable Generics Act (settlements) 3/07 S. 445, Patent Reform Act HR 1908, Patent Reform Act S 2300, Lower PRICED Drugs Act, legislation pediatric exclusivity, citizens petitions HR 6022, Lower PRICED Drugs Act, legislation on pediatric exclusivity, citizens petitions S 3695, To Amend the Federal Food, Drug & Cosmetic Act to prohibit the marketing of authorized generic drugs, authorized generics HR 5993, To amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs HR 5120, To Amend Title 35, United States Code, to confirm certain filing provisions within the Patent and Trademark Office. HR 5418, To establish a pilot program in certain United States district courts to encourage enhancement of expertise in patent cases among district judges S 438, Fair Prescription Drug Competition Act (ban authorized generics) 1/07 HR 780, Counterfeit Drug Prevention Act of 2007 3/07 HR 1908, Patent Reform Act of 2007 S 1145, Patent Reform Act of 2007 S 623, Access to Life-Saving Medication Act (FOBS) 2/07 HR 1038, Access to Life-Saving Medication Act HR 5629, Pathway For Biosimilars Act

S.Con Res. 21, Medicare and Medicaid, Budget Reconciliation, pharmaceutical counterfeiting, importation, AIDS Drug Assistance Programs Supplemental H. Con Res 99, Budget Reconciliation, pharmaceutical counterfeiting, importation HR. 2744, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2006,

H Con Res 99, Budget Reconciliation, pharmaceutical counterfeiting, importation S.Con Res 21, Budget Reconciliation, pharmaceutical counterfeiting, importation, AIDS Drug Assistance Programs Supplemental S Con Res 18, Budget reconciliation, pharmaceutical counterfeiting, importation S Con Res 21, Budget resolution, non-interference HR 3043, Department of Labor, Health and Human Services, and Education, and related Agencies Appropriation Act FY 2008, Pharmaceutical counterfeiting, Importation HR 3161, FY 2008 Agriculture Appropriations Bill (importation)

HR 1432, Preserve Access to Affordable Generics Act (settlements) S 316, Preserve Access to Affordable Generics Act (settlements) S 2300, Lower PRICED Drugs Act, legislation pediatric exclusivity, citizens petitions HR 6022, Lower PRICED Drugs Act, legislation on pediatric exclusivity, citizens petitions S 3695, To Amend the Federal Food, Drug & Cosmetic Act to prohibit the marketing of authorized generic drugs, authorized generics HR 5993, To amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs HR 5120, To Amend Title 35, United States Code, to confirm certain filing provisions within the Patent and Trademark Office. HR 5418, To establish a pilot program in certain United States district courts to encourage enhancement of expertise in patent cases among district judges S 438, Fair Prescription Drug Competition Act (ban authorized generics) HR 780, Counterfeit Drug Prevention Act of 2007 HR 1908, Patent Reform Act of 2007 S 1145, Patent Reform Act of 2007 S 623, Access to Life-Saving Medication Act (FOBS) HR 1038, Access to Life-Saving Medication Act

HR 1432, Preserve Access to Affordable Generics Act (settlements) S 316, Preserve Access to Affordable Generics Act (settlements) S 2300, Lower PRICED Drugs Act, legislation pediatric exclusivity, citizens petitions HR 6022, Lower PRICED Drugs Act, legislation on pediatric exclusivity, citizens petitions S 3695, To Amend the Federal Food, Drug & Cosmetic Act to prohibit the marketing of authorized generic drugs, authorized generics HR 5993, To amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs HR 5120, To Amend Title 35, United States Code, to confirm certain filing provisions within the Patent and Trademark Office. HR 5418, To establish a pilot program in certain United States district courts to encourage enhancement of expertise in patent cases among district judges S 438, Fair Prescription Drug Competition Act (ban authorized generics) HR 780, Counterfeit Drug Prevention Act of 2007 HR 1908, Patent Reform Act of 2007 S 1145, Patent Reform Act of 2007 S 623, Access to Life-Saving Medication Act (FOBS) HR 1038, Access to Life-Saving Medication Act

HR. 1432, Preserve Access to Affordable Generics Act (settlements) S. 316, Preserve Access to Affordable Generics Act (settlements)

HR 2406, (no title) authorize the NIST to increase its efforts in support of the integration the healthcare information enterprise in the United States. S 1693, The Wired for Heath Care Quality Act S. 438, Fair Prescription Drug Competition Act S. 1082, Food and Drug Administration Revitalization Act HR 806 S 358, Genetic Information Nondiscrimination Act S 1693, Wired for Health Quality Act HR 1432, Preserve Access to Affordable Generics Act S 316, Preserve Access to Affordable Generics Act HR 2406 Veterans' Healthcare issues

HR. 2138, R&D tax credit extension S. 41, R&D tax credit extension S. 41, S. 2209, HR. 1712, R&E tax credit Tax treaties with Belgium, Denmark, Finland and Germany

HR 1432, Preserve Access to Affordable Generics Act (settlements) S 316, Preserve Access to Affordable Generics Act (settlements) S 2300, Lower PRICED Drugs Act, legislation pediatric exclusivity, citizens petitions HR 6022, Lower PRICED Drugs Act, legislation on pediatric exclusivity, citizens petitions S 3695, To Amend the Federal Food, Drug & Cosmetic Act to prohibit the marketing of authorized generic drugs, authorized generics HR 5993, To amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs HR 5120, To Amend Title 35, United States Code, to confirm certain filing provisions within the Patent and Trademark Office. HR 5418, To establish a pilot program in certain United States district courts to encourage enhancement of expertise in patent cases among district judges S 438, Fair Prescription Drug Competition Act (ban authorized generics) HR 780, Counterfeit Drug Prevention Act of 2007 HR 1908, Patent Reform Act of 2007 S 1145, Patent Reform Act of 2007 S 623, Access to Life-Saving Medication Act (FOBS) HR 1038, Access to Life-Saving Medication Act

HR. 2138, R&D tax credit extension S. 41, R&D tax credit extension S. 41, S. 2209, HR. 1712, R&E tax credit Tax treaties with Belgium, Denmark, Finland and Germany

HR 4157, Better Health Information System Act, health information technology HR 5975, Prescription Drug Effectiveness Act, drug prescriptions S 2699, Neglected Diseases Elimination Act, promote R&D S 484, Enhancing Drug Safety and Innovation Act S 1082, FDA Revitalization Act HR 2900, FDA Amendments Act HR 2300, Lower PRICED Drugs Act, legislation on pediatric exclusivity, citizens petitions HR 870, The PhRMA Research and Manufacturers Accountability (PhRMA) Act, drug safety S 109, Pharmaceutical Market Access Act of 2005, pharmaceutical counterfeiting, importation HR 5156, Counterfeit Drug Prevention Act, pharmaceutical counterfeiting

HR 2406, (no title) authorize the NIST to increase its efforts in support of the integration the healthcare information enterprise in the United States. S 1693, The Wired for Heath Care Quality Act S. 438, Fair Prescription Drug Competition Act S. 1082, Food and Drug Administration Revitalization Act HR 806 S 358, Genetic Information Nondiscrimination Act S 1693, Wired for Health Quality Act HR 1432, Preserve Access to Affordable Generics Act S 316, Preserve Access to Affordable Generics Act HR 2406 Veterans' Healthcare issues

S.Con Res. 21, Medicare and Medicaid, Budget Reconciliation, pharmaceutical counterfeiting, importation, AIDS Drug Assistance Programs Supplemental H. Con Res 99, Budget Reconciliation, pharmaceutical counterfeiting, importation HR. 2744, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2006,

HR 2850, Green Chemistry Research and Development Act of 2007, environmental conservation

HR 2850, Green Chemistry Research and Development Act of 2007, environmental conservation

HR 4157, Better Health Information System Act, health information technology HR 5975, Prescription Drug Effectiveness Act, drug prescriptions S 2699, Neglected Diseases Elimination Act, promote R&D S 484, Enhancing Drug Safety and Innovation Act S 1082, FDA Revitalization Act HR 2900, FDA Amendments Act HR 2300, Lower PRICED Drugs Act, legislation on pediatric exclusivity, citizens petitions HR 870, The PhRMA Research and Manufacturers Accountability (PhRMA) Act, drug safety S 109, Pharmaceutical Market Access Act of 2005, pharmaceutical counterfeiting, importation HR 5156, Counterfeit Drug Prevention Act, pharmaceutical counterfeiting

HR 4, Medicare Prescription Drug Price Negotiation Act of 2007 S 3, Medicare Prescription Drug Price Negotiation Act of 2007

HR 4, Medicare Prescription Drug Price Negotiation Act of 2007 S 3, Medicare Prescription Drug Price Negotiation Act of 2007 Medicare prescription drug benefit implementation (no bills) - retain Medicaid rebates (no bills) Medicaid coverage (no bills) Average Manufacturer Price Regulation

HR 4157, Better Health Information System Act, health information technology HR 5975, Prescription Drug Effectiveness Act, drug prescriptions S 2699, Neglected Diseases Elimination Act, promote R&D S 484, Enhancing Drug Safety and Innovation Act S 1082, FDA Revitalization Act HR 2900, FDA Amendments Act HR 2300, Lower PRICED Drugs Act, legislation on pediatric exclusivity, citizens petitions HR 870, The PhRMA Research and Manufacturers Accountability (PhRMA) Act, drug safety S 109, Pharmaceutical Market Access Act of 2005, pharmaceutical counterfeiting, importation HR 5156, Counterfeit Drug Prevention Act, pharmaceutical counterfeiting

HR 1432, Preserve Access to Affordable Generics Act (settlements) S 316, Preserve Access to Affordable Generics Act (settlements) S 2300, Lower PRICED Drugs Act, legislation pediatric exclusivity, citizens petitions HR 6022, Lower PRICED Drugs Act, legislation on pediatric exclusivity, citizens petitions S 3695, To Amend the Federal Food, Drug & Cosmetic Act to prohibit the marketing of authorized generic drugs, authorized generics HR 5993, To amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs HR 5120, To Amend Title 35, United States Code, to confirm certain filing provisions within the Patent and Trademark Office. HR 5418, To establish a pilot program in certain United States district courts to encourage enhancement of expertise in patent cases among district judges S 438, Fair Prescription Drug Competition Act (ban authorized generics) HR 780, Counterfeit Drug Prevention Act of 2007 HR 1908, Patent Reform Act of 2007 S 1145, Patent Reform Act of 2007 S 623, Access to Life-Saving Medication Act (FOBS) HR 1038, Access to Life-Saving Medication Act

HR 870, The PhRMA Research and Manufacturers Accountability (PhRMA) Act, drug safety S 109, Pharmaceutical Market Access Act of 2005, pharmaceutical counterfeiting, importation HR 5156, Counterfeit Drug Prevention Act, pharmaceutical counterfeiting

HR 4157, Better Health Information System Act, health information technology HR 5975, Prescription Drug Effectiveness Act, drug prescriptions S 2699, Neglected Diseases Elimination Act, promote R&D S 484, Enhancing Drug Safety and Innovation Act S 1082, FDA Revitalization Act HR 2900, FDA Amendments Act HR 2300, Lower PRICED Drugs Act, legislation on pediatric exclusivity, citizens petitions HR 870, The PhRMA Research and Manufacturers Accountability (PhRMA) Act, drug safety S 109, Pharmaceutical Market Access Act of 2005, pharmaceutical counterfeiting, importation HR 5156, Counterfeit Drug Prevention Act, pharmaceutical counterfeiting

HR 1432, Preserve Access to Affordable Generics Act (settlements) S 316, Preserve Access to Affordable Generics Act (settlements) S 2300, Lower PRICED Drugs Act, legislation pediatric exclusivity, citizens petitions HR 6022, Lower PRICED Drugs Act, legislation on pediatric exclusivity, citizens petitions S 3695, To Amend the Federal Food, Drug & Cosmetic Act to prohibit the marketing of authorized generic drugs, authorized generics HR 5993, To amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs HR 5120, To Amend Title 35, United States Code, to confirm certain filing provisions within the Patent and Trademark Office. HR 5418, To establish a pilot program in certain United States district courts to encourage enhancement of expertise in patent cases among district judges S 438, Fair Prescription Drug Competition Act (ban authorized generics) HR 780, Counterfeit Drug Prevention Act of 2007 HR 1908, Patent Reform Act of 2007 S 1145, Patent Reform Act of 2007 S 623, Access to Life-Saving Medication Act (FOBS) HR 1038, Access to Life-Saving Medication Act

HR 4157, Better Health Information System Act, health information technology HR 5975, Prescription Drug Effectiveness Act, drug prescriptions S 2699, Neglected Diseases Elimination Act, promote R&D S 484, Enhancing Drug Safety and Innovation Act S 1082, FDA Revitalization Act HR 2900, FDA Amendments Act HR 2300, Lower PRICED Drugs Act, legislation on pediatric exclusivity, citizens petitions HR 870, The PhRMA Research and Manufacturers Accountability (PhRMA) Act, drug safety S 109, Pharmaceutical Market Access Act of 2005, pharmaceutical counterfeiting, importation HR 5156, Counterfeit Drug Prevention Act, pharmaceutical counterfeiting

HR 1432, Preserve Access to Affordable Generics Act (settlements) S 316, Preserve Access to Affordable Generics Act (settlements) S 2300, Lower PRICED Drugs Act, legislation pediatric exclusivity, citizens petitions HR 6022, Lower PRICED Drugs Act, legislation on pediatric exclusivity, citizens petitions S 3695, To Amend the Federal Food, Drug & Cosmetic Act to prohibit the marketing of authorized generic drugs, authorized generics HR 5993, To amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs HR 5120, To Amend Title 35, United States Code, to confirm certain filing provisions within the Patent and Trademark Office. HR 5418, To establish a pilot program in certain United States district courts to encourage enhancement of expertise in patent cases among district judges S 438, Fair Prescription Drug Competition Act (ban authorized generics) HR 780, Counterfeit Drug Prevention Act of 2007 HR 1908, Patent Reform Act of 2007 S 1145, Patent Reform Act of 2007 S 623, Access to Life-Saving Medication Act (FOBS) HR 1038, Access to Life-Saving Medication Act

HR 1432, Preserve Access to Affordable Generics Act (settlements) S 316, Preserve Access to Affordable Generics Act (settlements) S 2300, Lower PRICED Drugs Act, legislation pediatric exclusivity, citizens petitions HR 6022, Lower PRICED Drugs Act, legislation on pediatric exclusivity, citizens petitions S 3695, To Amend the Federal Food, Drug & Cosmetic Act to prohibit the marketing of authorized generic drugs, authorized generics HR 5993, To amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs HR 5120, To Amend Title 35, United States Code, to confirm certain filing provisions within the Patent and Trademark Office. HR 5418, To establish a pilot program in certain United States district courts to encourage enhancement of expertise in patent cases among district judges S 438, Fair Prescription Drug Competition Act (ban authorized generics) HR 780, Counterfeit Drug Prevention Act of 2007 HR 1908, Patent Reform Act of 2007 S 1145, Patent Reform Act of 2007 S 623, Access to Life-Saving Medication Act (FOBS) HR 1038, Access to Life-Saving Medication Act

HR 1432, Preserve Access to Affordable Generics Act (settlements) S 316, Preserve Access to Affordable Generics Act (settlements) S 2300, Lower PRICED Drugs Act, legislation pediatric exclusivity, citizens petitions HR 6022, Lower PRICED Drugs Act, legislation on pediatric exclusivity, citizens petitions S 3695, To Amend the Federal Food, Drug & Cosmetic Act to prohibit the marketing of authorized generic drugs, authorized generics HR 5993, To amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs HR 5120, To Amend Title 35, United States Code, to confirm certain filing provisions within the Patent and Trademark Office. HR 5418, To establish a pilot program in certain United States district courts to encourage enhancement of expertise in patent cases among district judges S 438, Fair Prescription Drug Competition Act (ban authorized generics) HR 780, Counterfeit Drug Prevention Act of 2007 HR 1908, Patent Reform Act of 2007 S 1145, Patent Reform Act of 2007 S 623, Access to Life-Saving Medication Act (FOBS) HR 1038, Access to Life-Saving Medication Act

HR 2406, (no title) authorize the NIST to increase its efforts in support of the integration the healthcare information enterprise in the United States. S 1693, The Wired for Heath Care Quality Act S. 438, Fair Prescription Drug Competition Act S. 1082, Food and Drug Administration Revitalization Act HR 806 S 358, Genetic Information Nondiscrimination Act S 1693, Wired for Health Quality Act HR 1432, Preserve Access to Affordable Generics Act S 316, Preserve Access to Affordable Generics Act HR 2406 Veterans' Healthcare issues

HR 4157, Better Health Information System Act, health information technology HR 5975, Prescription Drug Effectiveness Act, drug prescriptions S 2699, Neglected Diseases Elimination Act, promote R&D S 484, Enhancing Drug Safety and Innovation Act S 1082, FDA Revitalization Act HR 2900, FDA Amendments Act HR 2300, Lower PRICED Drugs Act, legislation on pediatric exclusivity, citizens petitions HR 870, The PhRMA Research and Manufacturers Accountability (PhRMA) Act, drug safety S 109, Pharmaceutical Market Access Act of 2005, pharmaceutical counterfeiting, importation HR 5156, Counterfeit Drug Prevention Act, pharmaceutical counterfeiting

HR 870, The PhRMA Research and Manufacturers Accountability (PhRMA) Act, drug safety S 109, Pharmaceutical Market Access Act of 2005, pharmaceutical counterfeiting, importation HR 5156, Counterfeit Drug Prevention Act, pharmaceutical counterfeiting

HR 1432, Preserve Access to Affordable Generics Act (settlements) S 316, Preserve Access to Affordable Generics Act (settlements) S 2300, Lower PRICED Drugs Act, legislation pediatric exclusivity, citizens petitions HR 6022, Lower PRICED Drugs Act, legislation on pediatric exclusivity, citizens petitions S 3695, To Amend the Federal Food, Drug & Cosmetic Act to prohibit the marketing of authorized generic drugs, authorized generics HR 5993, To amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs HR 5120, To Amend Title 35, United States Code, to confirm certain filing provisions within the Patent and Trademark Office. HR 5418, To establish a pilot program in certain United States district courts to encourage enhancement of expertise in patent cases among district judges S 438, Fair Prescription Drug Competition Act (ban authorized generics) HR 780, Counterfeit Drug Prevention Act of 2007 HR 1908, Patent Reform Act of 2007 S 1145, Patent Reform Act of 2007 S 623, Access to Life-Saving Medication Act (FOBS) HR 1038, Access to Life-Saving Medication Act

HR 2406, (no title) authorize the NIST to increase its efforts in support of the integration the healthcare information enterprise in the United States. S 1693, The Wired for Heath Care Quality Act S. 438, Fair Prescription Drug Competition Act S. 1082, Food and Drug Administration Revitalization Act HR 806 S 358, Genetic Information Nondiscrimination Act S 1693, Wired for Health Quality Act HR 1432, Preserve Access to Affordable Generics Act S 316, Preserve Access to Affordable Generics Act HR 2406 Veterans' Healthcare issues

HR. 2138, R&D tax credit extension S. 41, R&D tax credit extension S. 41, S. 2209, HR. 1712, R&E tax credit Tax treaties with Belgium, Denmark, Finland and Germany

HR 4, Medicare Prescription Drug Price Negotiation Act of 2007 S 3, Medicare Prescription Drug Price Negotiation Act of 2007 Medicare prescription drug benefit implementation (no bills) - retain Medicaid rebates (no bills) Medicaid coverage (no bills) Average Manufacturer Price Regulation

HR 4, Medicare Prescription Drug Price Negotiation Act of 2007 S 3, Medicare Prescription Drug Price Negotiation Act of 2007

HR. 1432, Preserve Access to Affordable Generics Act (settlements) S. 316, Preserve Access to Affordable Generics Act (settlements)

HR 2406, (no title) authorize the NIST to increase its efforts in support of the integration the healthcare information enterprise in the United States. S 1693, The Wired for Heath Care Quality Act S. 438, Fair Prescription Drug Competition Act S. 1082, Food and Drug Administration Revitalization Act HR 806 S 358, Genetic Information Nondiscrimination Act S 1693, Wired for Health Quality Act HR 1432, Preserve Access to Affordable Generics Act S 316, Preserve Access to Affordable Generics Act HR 2406 Veterans' Healthcare issues

HR 1432, Preserve Access to Affordable Generics Act (settlements) S 316, Preserve Access to Affordable Generics Act (settlements) S 2300, Lower PRICED Drugs Act, legislation pediatric exclusivity, citizens petitions HR 6022, Lower PRICED Drugs Act, legislation on pediatric exclusivity, citizens petitions S 3695, To Amend the Federal Food, Drug & Cosmetic Act to prohibit the marketing of authorized generic drugs, authorized generics HR 5993, To amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs HR 5120, To Amend Title 35, United States Code, to confirm certain filing provisions within the Patent and Trademark Office. HR 5418, To establish a pilot program in certain United States district courts to encourage enhancement of expertise in patent cases among district judges S 438, Fair Prescription Drug Competition Act (ban authorized generics) HR 780, Counterfeit Drug Prevention Act of 2007 HR 1908, Patent Reform Act of 2007 S 1145, Patent Reform Act of 2007 S 623, Access to Life-Saving Medication Act (FOBS) HR 1038, Access to Life-Saving Medication Act

HR 2406, (no title) authorize the NIST to increase its efforts in support of the integration the healthcare information enterprise in the United States. S 1693, The Wired for Heath Care Quality Act S. 438, Fair Prescription Drug Competition Act S. 1082, Food and Drug Administration Revitalization Act HR 806 S 358, Genetic Information Nondiscrimination Act S 1693, Wired for Health Quality Act HR 1432, Preserve Access to Affordable Generics Act S 316, Preserve Access to Affordable Generics Act HR 2406 Veterans' Healthcare issues

HR. 2138, R&D tax credit extension S. 41, R&D tax credit extension S. 41, S. 2209, HR. 1712, R&E tax credit Tax treaties with Belgium, Denmark, Finland and Germany

HR 1432, Preserve Access to Affordable Generics Act (settlements) S 316, Preserve Access to Affordable Generics Act (settlements) S 2300, Lower PRICED Drugs Act, legislation pediatric exclusivity, citizens petitions HR 6022, Lower PRICED Drugs Act, legislation on pediatric exclusivity, citizens petitions S 3695, To Amend the Federal Food, Drug & Cosmetic Act to prohibit the marketing of authorized generic drugs, authorized generics HR 5993, To amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs HR 5120, To Amend Title 35, United States Code, to confirm certain filing provisions within the Patent and Trademark Office. HR 5418, To establish a pilot program in certain United States district courts to encourage enhancement of expertise in patent cases among district judges S 438, Fair Prescription Drug Competition Act (ban authorized generics) HR 780, Counterfeit Drug Prevention Act of 2007 HR 1908, Patent Reform Act of 2007 S 1145, Patent Reform Act of 2007 S 623, Access to Life-Saving Medication Act (FOBS) HR 1038, Access to Life-Saving Medication Act

HR 2406, (no title) authorize the NIST to increase its efforts in support of the integration the healthcare information enterprise in the United States. S 1693, The Wired for Heath Care Quality Act S. 438, Fair Prescription Drug Competition Act S. 1082, Food and Drug Administration Revitalization Act HR 806 S 358, Genetic Information Nondiscrimination Act S 1693, Wired for Health Quality Act HR 1432, Preserve Access to Affordable Generics Act S 316, Preserve Access to Affordable Generics Act HR 2406 Veterans' Healthcare issues

HR 4157, Better Health Information System Act, health information technology HR 5975, Prescription Drug Effectiveness Act, drug prescriptions S 2699, Neglected Diseases Elimination Act, promote R&D S 484, Enhancing Drug Safety and Innovation Act S 1082, FDA Revitalization Act HR 2900, FDA Amendments Act HR 2300, Lower PRICED Drugs Act, legislation on pediatric exclusivity, citizens petitions HR 870, The PhRMA Research and Manufacturers Accountability (PhRMA) Act, drug safety S 109, Pharmaceutical Market Access Act of 2005, pharmaceutical counterfeiting, importation HR 5156, Counterfeit Drug Prevention Act, pharmaceutical counterfeiting

HR 1432, Preserve Access to Affordable Generics Act (settlements) S 316, Preserve Access to Affordable Generics Act (settlements) S 2300, Lower PRICED Drugs Act, legislation pediatric exclusivity, citizens petitions HR 6022, Lower PRICED Drugs Act, legislation on pediatric exclusivity, citizens petitions S 3695, To Amend the Federal Food, Drug & Cosmetic Act to prohibit the marketing of authorized generic drugs, authorized generics HR 5993, To amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs HR 5120, To Amend Title 35, United States Code, to confirm certain filing provisions within the Patent and Trademark Office. HR 5418, To establish a pilot program in certain United States district courts to encourage enhancement of expertise in patent cases among district judges S 438, Fair Prescription Drug Competition Act (ban authorized generics) HR 780, Counterfeit Drug Prevention Act of 2007 HR 1908, Patent Reform Act of 2007 S 1145, Patent Reform Act of 2007 S 623, Access to Life-Saving Medication Act (FOBS) HR 1038, Access to Life-Saving Medication Act

H Con Res 99, Budget Reconciliation, pharmaceutical counterfeiting, importation S.Con Res 21, Budget Reconciliation, pharmaceutical counterfeiting, importation, AIDS Drug Assistance Programs Supplemental S Con Res 18, Budget reconciliation, pharmaceutical counterfeiting, importation S Con Res 21, Budget resolution, non-interference HR 3043, Department of Labor, Health and Human Services, and Education, and related Agencies Appropriation Act FY 2008, Pharmaceutical counterfeiting, Importation HR 3161, FY 2008 Agriculture Appropriations Bill (importation)

HR 870, The PhRMA Research and Manufacturers Accountability (PhRMA) Act, drug safety S 109, Pharmaceutical Market Access Act of 2005, pharmaceutical counterfeiting, importation HR 5156, Counterfeit Drug Prevention Act, pharmaceutical counterfeiting

HR 4157, Better Health Information System Act, health information technology HR 5975, Prescription Drug Effectiveness Act, drug prescriptions S 2699, Neglected Diseases Elimination Act, promote R&D S 484, Enhancing Drug Safety and Innovation Act S 1082, FDA Revitalization Act HR 2900, FDA Amendments Act HR 2300, Lower PRICED Drugs Act, legislation on pediatric exclusivity, citizens petitions HR 870, The PhRMA Research and Manufacturers Accountability (PhRMA) Act, drug safety S 109, Pharmaceutical Market Access Act of 2005, pharmaceutical counterfeiting, importation HR 5156, Counterfeit Drug Prevention Act, pharmaceutical counterfeiting

HR 1432, Preserve Access to Affordable Generics Act (settlements) S 316, Preserve Access to Affordable Generics Act (settlements) S 2300, Lower PRICED Drugs Act, legislation pediatric exclusivity, citizens petitions HR 6022, Lower PRICED Drugs Act, legislation on pediatric exclusivity, citizens petitions S 3695, To Amend the Federal Food, Drug & Cosmetic Act to prohibit the marketing of authorized generic drugs, authorized generics HR 5993, To amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs HR 5120, To Amend Title 35, United States Code, to confirm certain filing provisions within the Patent and Trademark Office. HR 5418, To establish a pilot program in certain United States district courts to encourage enhancement of expertise in patent cases among district judges S 438, Fair Prescription Drug Competition Act (ban authorized generics) HR 780, Counterfeit Drug Prevention Act of 2007 HR 1908, Patent Reform Act of 2007 S 1145, Patent Reform Act of 2007 S 623, Access to Life-Saving Medication Act (FOBS) HR 1038, Access to Life-Saving Medication Act

HR 4157, Better Health Information System Act, health information technology HR 5975, Prescription Drug Effectiveness Act, drug prescriptions S 2699, Neglected Diseases Elimination Act, promote R&D S 484, Enhancing Drug Safety and Innovation Act S 1082, FDA Revitalization Act HR 2900, FDA Amendments Act HR 2300, Lower PRICED Drugs Act, legislation on pediatric exclusivity, citizens petitions HR 870, The PhRMA Research and Manufacturers Accountability (PhRMA) Act, drug safety S 109, Pharmaceutical Market Access Act of 2005, pharmaceutical counterfeiting, importation HR 5156, Counterfeit Drug Prevention Act, pharmaceutical counterfeiting

HR 1432, Preserve Access to Affordable Generics Act (settlements) S 316, Preserve Access to Affordable Generics Act (settlements) S 2300, Lower PRICED Drugs Act, legislation pediatric exclusivity, citizens petitions HR 6022, Lower PRICED Drugs Act, legislation on pediatric exclusivity, citizens petitions S 3695, To Amend the Federal Food, Drug & Cosmetic Act to prohibit the marketing of authorized generic drugs, authorized generics HR 5993, To amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs HR 5120, To Amend Title 35, United States Code, to confirm certain filing provisions within the Patent and Trademark Office. HR 5418, To establish a pilot program in certain United States district courts to encourage enhancement of expertise in patent cases among district judges S 438, Fair Prescription Drug Competition Act (ban authorized generics) HR 780, Counterfeit Drug Prevention Act of 2007 HR 1908, Patent Reform Act of 2007 S 1145, Patent Reform Act of 2007 S 623, Access to Life-Saving Medication Act (FOBS) HR 1038, Access to Life-Saving Medication Act

S 3807, Enhancing Drug Safety and Innovation Act of 2006, drug safety, DTC

S 3807, Enhancing Drug Safety and Innovation Act of 2006, drug safety, DTC

HR 2206, Veterinary Workforce Expansion Act of 2005, increased funding for veterinary schools HR 3161, Agriculture Appropriations, pharmaceutical counterfeiting, importation S 914, Veterinary Workforce Expansion Act of 2005, increased funding for veterinary schools

HR. 2206, Veterinarh Workforce Expansion Act of 2005, increased funding for veterinary schools HR. 3161, Agriculture Appropriations, pharmaceutical counterfeiting, importation S. 914, Veterinary Workforce Expansion Act of 2005, increased funding for veterinary schools

HR 2206, Veterinary Workforce Expansion Act of 2005, increased funding for veterinary schools HR 3161, Agriculture Appropriations, pharmaceutical counterfeiting, importation S 914, Veterinary Workforce Expansion Act of 2005, increased funding for veterinary schools

HR. 2206, Veterinarh Workforce Expansion Act of 2005, increased funding for veterinary schools HR. 3161, Agriculture Appropriations, pharmaceutical counterfeiting, importation S. 914, Veterinary Workforce Expansion Act of 2005, increased funding for veterinary schools

HR 328, Pharmaceutical Market Access Act of 2005, pharmaceutical counterfeiting, importation HR 700, Pharmaceutical Market Access and Drug Safety Act of 2005, pharmaceutical counterfeiting, imporation, patent issues S 109, Pharmaceutical Market Access Act of 2005, pharmaceutical counterfeiting, importation S 334, Pharmaceutical Market Access and Drug Safety Act of 2005, pharmaceutical counterfeiting, importation, patent issues S 2300, Lower PRICED Drugs Act, legislation on pediatric exclusivity, citizens petitions HR 6022, Lower PRICED Drugs Act, legislation on pediatric exclusivity, citizens petitions S 3695, To Amend the Federal Food, Drug & Cosmetic Act to prohibit the marketing of authorized generic drugs, authorized generics HR 5993, To Amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs HR 5120, To amend title 35, United States Code, to conform certain filing provisions within the Patent and Trademark Office. HR 5418, To establish a pilot program in certain United States district courts to encourage enhancement of expertise in patent cases among district judges S 3818, Patent Reform Act of 2006 S 3175, Life-Saving Medicines Export Act of 2006, compulsory licensing S 3834, Online Pharmacy Consumer Protection Act of 2006, prescription drugs S 1903, Generic Prescription Drug Fairness Act of 2005, authorized generics and rebates

HR 328, Pharmaceutical Market Access Act of 2005, pharmaceutical counterfeiting, importation HR 700, Pharmaceutical Market Access and Drug Safety Act of 2005, pharmaceutical counterfeiting, imporation, patent issues S 109, Pharmaceutical Market Access Act of 2005, pharmaceutical counterfeiting, importation S 334, Pharmaceutical Market Access and Drug Safety Act of 2005, pharmaceutical counterfeiting, importation, patent issues S 2300, Lower PRICED Drugs Act, legislation on pediatric exclusivity, citizens petitions HR 6022, Lower PRICED Drugs Act, legislation on pediatric exclusivity, citizens petitions S 3695, To Amend the Federal Food, Drug & Cosmetic Act to prohibit the marketing of authorized generic drugs, authorized generics HR 5993, To Amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs HR 5120, To amend title 35, United States Code, to conform certain filing provisions within the Patent and Trademark Office. HR 5418, To establish a pilot program in certain United States district courts to encourage enhancement of expertise in patent cases among district judges S 3818, Patent Reform Act of 2006 S 3175, Life-Saving Medicines Export Act of 2006, compulsory licensing S 3834, Online Pharmacy Consumer Protection Act of 2006, prescription drugs S 1903, Generic Prescription Drug Fairness Act of 2005, authorized generics and rebates

HR 700, Pharmaceutical Market Access and Drug Safety Act of 2005, pharmaceutical counterfeiting, importation, patent issues HR 870, The PhRMA Research and Manufacturers Accountability (PhRMA) Act, drug safety S 109, Pharmaceutical Market Access Act of 2005, pharmaceutical counterfeiting, importation S 334, Pharmaceutical Market Access and Drug Safety Act of 2005, pharmaceutical counterfeiting, importation, patent issues S 470, The Fair Access to Clinical Trials ("FACT") Act of 2005, drug safety S 930, Food and Drug Administration Safety Act of 2005, drug safety HR 5156, Counterfeit Drug Prevention Act, pharmaceutical counterfeiting S 3834, Online Pharmacy Consumer Protection Act of 2006, drug safety HR 2300, Lower PRICED Drugs Act, legislation on pediatric exclusivity, citizens petitions HR 4157, Better Health Information System Act, health information technology HR 5975, Prescription Drug Effectiveness Act, drug prescriptions S 2699, Neglected Diseases Elimination Act, promote R&D HR 2090, The Food and Drug Administration Improvement Act of 2005, drug safety HR 3196, The Fair Access to Clinical Trials ("RACT") Act of 2005, drug safety HR 328, Pharmaceutical Market Access Act of 2005, pharmaceutical counterfeiting, importation, drug safety

S 109, Pharmaceutical Market Access Act of 2005, pharmaceutical counterfeiting, importation S 334, Pharmaceutical Market Access and Drug Safety Act of 2005, pharmaceutical counterfeiting, importation, patent issues HR 3010, Department of Labor, Health and Human Service, and Education, and Related Agencies Appropriations Act, 2006, access to prescription drugs HR 3971, Social Services Emergency Relief and Recovery Act of 2005, access to prescription drugs HR 5993, Authorized Generics Prohibition, authorized generics S 3695, Authorized Generics Prohibition, authorized generics HR 4157, Better Health Information System Act, health information technology S 2300, Lower PRICED Drug Act, generic drug access, legislation on pediatric exclusivity, citizens petitions HR 6134, Ryan White Care Act, reauthorization S 2339, Ryan White Care Act, reauthorization HR 5975, Prescription Drug Comparative Effectiveness Act, drug prescriptions S 1355, Better Healthcare Through Information Technology Act, health information technology HR 6289, Personalized Health Information Act of 2006, health information technology HR 328, Pharmaceutical Market Access Act of 2005, pharmaceutical counterfeiting, importation HR 700, Pharmaceutical Market Access and Drug Safety Act of 2005, pharmaceutical counterfeiting, importation, patent issues

HR 700, Pharmaceutical Market Access and Drug Safety Act of 2005, pharmaceutical counterfeiting, importation, patent issues HR 870, The PhRMA Research and Manufacturers Accountability (PhRMA) Act, drug safety S 109, Pharmaceutical Market Access Act of 2005, pharmaceutical counterfeiting, importation S 334, Pharmaceutical Market Access and Drug Safety Act of 2005, pharmaceutical counterfeiting, importation, patent issues S 470, The Fair Access to Clinical Trials ("FACT") Act of 2005, drug safety S 930, Food and Drug Administration Safety Act of 2005, drug safety HR 5156, Counterfeit Drug Prevention Act, pharmaceutical counterfeiting S 3834, Online Pharmacy Consumer Protection Act of 2006, drug safety HR 2300, Lower PRICED Drugs Act, legislation on pediatric exclusivity, citizens petitions HR 4157, Better Health Information System Act, health information technology HR 5975, Prescription Drug Effectiveness Act, drug prescriptions S 2699, Neglected Diseases Elimination Act, promote R&D HR 2090, The Food and Drug Administration Improvement Act of 2005, drug safety HR 3196, The Fair Access to Clinical Trials ("RACT") Act of 2005, drug safety HR 328, Pharmaceutical Market Access Act of 2005, pharmaceutical counterfeiting, importation, drug safety

S 109, Pharmaceutical Market Access Act of 2005, pharmaceutical counterfeiting, importation S 334, Pharmaceutical Market Access and Drug Safety Act of 2005, pharmaceutical counterfeiting, importation, patent issues HR 3010, Department of Labor, Health and Human Service, and Education, and Related Agencies Appropriations Act, 2006, access to prescription drugs HR 3971, Social Services Emergency Relief and Recovery Act of 2005, access to prescription drugs HR 5993, Authorized Generics Prohibition, authorized generics S 3695, Authorized Generics Prohibition, authorized generics HR 4157, Better Health Information System Act, health information technology S 2300, Lower PRICED Drug Act, generic drug access, legislation on pediatric exclusivity, citizens petitions HR 6134, Ryan White Care Act, reauthorization S 2339, Ryan White Care Act, reauthorization HR 5975, Prescription Drug Comparative Effectiveness Act, drug prescriptions S 1355, Better Healthcare Through Information Technology Act, health information technology HR 6289, Personalized Health Information Act of 2006, health information technology HR 328, Pharmaceutical Market Access Act of 2005, pharmaceutical counterfeiting, importation HR 700, Pharmaceutical Market Access and Drug Safety Act of 2005, pharmaceutical counterfeiting, importation, patent issues

HR 1215 Green Chemistry Research and Development Act of 2005, environmental conservation S 1270, Green Chemistry Research and Development Act of 2005, environmental conservation

HR 1215 Green Chemistry Research and Development Act of 2005, environmental conservation S 1270, Green Chemistry Research and Development Act of 2005, environmental conservation

S 109, Pharmaceutical Market Access Act of 2005, pharmaceutical counterfeiting, importation S 334, Pharmaceutical Market Access and Drug Safety Act of 2005, pharmaceutical counterfeiting, importation, patent issues HR 3010, Department of Labor, Health and Human Service, and Education, and Related Agencies Appropriations Act, 2006, access to prescription drugs HR 3971, Social Services Emergency Relief and Recovery Act of 2005, access to prescription drugs HR 5993, Authorized Generics Prohibition, authorized generics S 3695, Authorized Generics Prohibition, authorized generics HR 4157, Better Health Information System Act, health information technology S 2300, Lower PRICED Drug Act, generic drug access, legislation on pediatric exclusivity, citizens petitions HR 6134, Ryan White Care Act, reauthorization S 2339, Ryan White Care Act, reauthorization HR 5975, Prescription Drug Comparative Effectiveness Act, drug prescriptions S 1355, Better Healthcare Through Information Technology Act, health information technology HR 6289, Personalized Health Information Act of 2006, health information technology HR 328, Pharmaceutical Market Access Act of 2005, pharmaceutical counterfeiting, importation HR 700, Pharmaceutical Market Access and Drug Safety Act of 2005, pharmaceutical counterfeiting, importation, patent issues

S 109, Pharmaceutical Market Access Act of 2005, pharmaceutical counterfeiting, importation S 334, Pharmaceutical Market Access and Drug Safety Act of 2005, pharmaceutical counterfeiting, importation, patent issues HR 3010, Department of Labor, Health and Human Service, and Education, and Related Agencies Appropriations Act, 2006, access to prescription drugs HR 3971, Social Services Emergency Relief and Recovery Act of 2005, access to prescription drugs HR 5993, Authorized Generics Prohibition, authorized generics S 3695, Authorized Generics Prohibition, authorized generics HR 4157, Better Health Information System Act, health information technology S 2300, Lower PRICED Drug Act, generic drug access, legislation on pediatric exclusivity, citizens petitions HR 6134, Ryan White Care Act, reauthorization S 2339, Ryan White Care Act, reauthorization HR 5975, Prescription Drug Comparative Effectiveness Act, drug prescriptions S 1355, Better Healthcare Through Information Technology Act, health information technology HR 6289, Personalized Health Information Act of 2006, health information technology HR 328, Pharmaceutical Market Access Act of 2005, pharmaceutical counterfeiting, importation HR 700, Pharmaceutical Market Access and Drug Safety Act of 2005, pharmaceutical counterfeiting, importation, patent issues

HR 328, Pharmaceutical Market Access Act of 2005, pharmaceutical counterfeiting, importation HR 700, Pharmaceutical Market Access and Drug Safety Act of 2005, pharmaceutical counterfeiting, imporation, patent issues S 109, Pharmaceutical Market Access Act of 2005, pharmaceutical counterfeiting, importation S 334, Pharmaceutical Market Access and Drug Safety Act of 2005, pharmaceutical counterfeiting, importation, patent issues S 2300, Lower PRICED Drugs Act, legislation on pediatric exclusivity, citizens petitions HR 6022, Lower PRICED Drugs Act, legislation on pediatric exclusivity, citizens petitions S 3695, To Amend the Federal Food, Drug & Cosmetic Act to prohibit the marketing of authorized generic drugs, authorized generics HR 5993, To Amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs HR 5120, To amend title 35, United States Code, to conform certain filing provisions within the Patent and Trademark Office. HR 5418, To establish a pilot program in certain United States district courts to encourage enhancement of expertise in patent cases among district judges S 3818, Patent Reform Act of 2006 S 3175, Life-Saving Medicines Export Act of 2006, compulsory licensing S 3834, Online Pharmacy Consumer Protection Act of 2006, prescription drugs S 1903, Generic Prescription Drug Fairness Act of 2005, authorized generics and rebates

HR 328, Pharmaceutical Market Access Act of 2005, pharmaceutical counterfeiting, importation HR 700, Pharmaceutical Market Access and Drug Safety Act of 2005, pharmaceutical counterfeiting, imporation, patent issues S 109, Pharmaceutical Market Access Act of 2005, pharmaceutical counterfeiting, importation S 334, Pharmaceutical Market Access and Drug Safety Act of 2005, pharmaceutical counterfeiting, importation, patent issues S 2300, Lower PRICED Drugs Act, legislation on pediatric exclusivity, citizens petitions HR 6022, Lower PRICED Drugs Act, legislation on pediatric exclusivity, citizens petitions S 3695, To Amend the Federal Food, Drug & Cosmetic Act to prohibit the marketing of authorized generic drugs, authorized generics HR 5993, To Amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs HR 5120, To amend title 35, United States Code, to conform certain filing provisions within the Patent and Trademark Office. HR 5418, To establish a pilot program in certain United States district courts to encourage enhancement of expertise in patent cases among district judges S 3818, Patent Reform Act of 2006 S 3175, Life-Saving Medicines Export Act of 2006, compulsory licensing S 3834, Online Pharmacy Consumer Protection Act of 2006, prescription drugs S 1903, Generic Prescription Drug Fairness Act of 2005, authorized generics and rebates

S 1926, Animal Enterprise Terrorism Act, research safety HR 4239, Animal Enterprise Terrorism Act, research safety animal health (no bills)

S 1926, Animal Enterprise Terrorism Act, research safety HR 4239, Animal Enterprise Terrorism Act, research safety animal health (no bills)

HR 328, Pharmaceutical Market Access Act of 2005, pharmaceutical counterfeiting, importation HR 700, Pharmaceutical Market Access and Drug Safety Act of 2005, pharmaceutical counterfeiting, imporation, patent issues S 109, Pharmaceutical Market Access Act of 2005, pharmaceutical counterfeiting, importation S 334, Pharmaceutical Market Access and Drug Safety Act of 2005, pharmaceutical counterfeiting, importation, patent issues S 2300, Lower PRICED Drugs Act, legislation on pediatric exclusivity, citizens petitions HR 6022, Lower PRICED Drugs Act, legislation on pediatric exclusivity, citizens petitions S 3695, To Amend the Federal Food, Drug & Cosmetic Act to prohibit the marketing of authorized generic drugs, authorized generics HR 5993, To Amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs HR 5120, To amend title 35, United States Code, to conform certain filing provisions within the Patent and Trademark Office. HR 5418, To establish a pilot program in certain United States district courts to encourage enhancement of expertise in patent cases among district judges S 3818, Patent Reform Act of 2006 S 3175, Life-Saving Medicines Export Act of 2006, compulsory licensing S 3834, Online Pharmacy Consumer Protection Act of 2006, prescription drugs S 1903, Generic Prescription Drug Fairness Act of 2005, authorized generics and rebates

HR 328, Pharmaceutical Market Access Act of 2005, pharmaceutical counterfeiting, importation HR 700, Pharmaceutical Market Access and Drug Safety Act of 2005, pharmaceutical counterfeiting, imporation, patent issues S 109, Pharmaceutical Market Access Act of 2005, pharmaceutical counterfeiting, importation S 334, Pharmaceutical Market Access and Drug Safety Act of 2005, pharmaceutical counterfeiting, importation, patent issues S 2300, Lower PRICED Drugs Act, legislation on pediatric exclusivity, citizens petitions HR 6022, Lower PRICED Drugs Act, legislation on pediatric exclusivity, citizens petitions S 3695, To Amend the Federal Food, Drug & Cosmetic Act to prohibit the marketing of authorized generic drugs, authorized generics HR 5993, To Amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs HR 5120, To amend title 35, United States Code, to conform certain filing provisions within the Patent and Trademark Office. HR 5418, To establish a pilot program in certain United States district courts to encourage enhancement of expertise in patent cases among district judges S 3818, Patent Reform Act of 2006 S 3175, Life-Saving Medicines Export Act of 2006, compulsory licensing S 3834, Online Pharmacy Consumer Protection Act of 2006, prescription drugs S 1903, Generic Prescription Drug Fairness Act of 2005, authorized generics and rebates

S 109, Pharmaceutical Market Access Act of 2005, pharmaceutical counterfeiting, importation S 334, Pharmaceutical Market Access and Drug Safety Act of 2005, pharmaceutical counterfeiting, importation, patent issues HR 3010, Department of Labor, Health and Human Service, and Education, and Related Agencies Appropriations Act, 2006, access to prescription drugs HR 3971, Social Services Emergency Relief and Recovery Act of 2005, access to prescription drugs HR 5993, Authorized Generics Prohibition, authorized generics S 3695, Authorized Generics Prohibition, authorized generics HR 4157, Better Health Information System Act, health information technology S 2300, Lower PRICED Drug Act, generic drug access, legislation on pediatric exclusivity, citizens petitions HR 6134, Ryan White Care Act, reauthorization S 2339, Ryan White Care Act, reauthorization HR 5975, Prescription Drug Comparative Effectiveness Act, drug prescriptions S 1355, Better Healthcare Through Information Technology Act, health information technology HR 6289, Personalized Health Information Act of 2006, health information technology HR 328, Pharmaceutical Market Access Act of 2005, pharmaceutical counterfeiting, importation HR 700, Pharmaceutical Market Access and Drug Safety Act of 2005, pharmaceutical counterfeiting, importation, patent issues

S 109, Pharmaceutical Market Access Act of 2005, pharmaceutical counterfeiting, importation S 334, Pharmaceutical Market Access and Drug Safety Act of 2005, pharmaceutical counterfeiting, importation, patent issues HR 3010, Department of Labor, Health and Human Service, and Education, and Related Agencies Appropriations Act, 2006, access to prescription drugs HR 3971, Social Services Emergency Relief and Recovery Act of 2005, access to prescription drugs HR 5993, Authorized Generics Prohibition, authorized generics S 3695, Authorized Generics Prohibition, authorized generics HR 4157, Better Health Information System Act, health information technology S 2300, Lower PRICED Drug Act, generic drug access, legislation on pediatric exclusivity, citizens petitions HR 6134, Ryan White Care Act, reauthorization S 2339, Ryan White Care Act, reauthorization HR 5975, Prescription Drug Comparative Effectiveness Act, drug prescriptions S 1355, Better Healthcare Through Information Technology Act, health information technology HR 6289, Personalized Health Information Act of 2006, health information technology HR 328, Pharmaceutical Market Access Act of 2005, pharmaceutical counterfeiting, importation HR 700, Pharmaceutical Market Access and Drug Safety Act of 2005, pharmaceutical counterfeiting, importation, patent issues

H Con Res 95, Budget Reconciliation, pharmaceutical counterfeiting, importation HR 2744, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2006, pharmaceutical counterfeiting, importation HR 2862, Science, State, Justice, Commerce, and Related Agencies Appropriations Act, 2006, pharmaceutical counterfeiting, importation HR 3010, Departments of Labor, Health and Human Services, and Education, and related Agencies Appropriations Act, 2006, pharmaceutical counterfeiting, importation S Con Res 18, Budget reconciliation, pharmaceutical counterfeiting, importation S Con Res 83, Budget resolution, non-interference HR 6134, Ryan White Care Act, appropriations S 2339, Ryan White Care Act, appropriations

H Con Res 95, Budget Reconciliation, pharmaceutical counterfeiting, importation HR 2744, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2006, pharmaceutical counterfeiting, importation HR 2862, Science, State, Justice, Commerce, and Related Agencies Appropriations Act, 2006, pharmaceutical counterfeiting, importation HR 3010, Departments of Labor, Health and Human Services, and Education, and related Agencies Appropriations Act, 2006, pharmaceutical counterfeiting, importation S Con Res 18, Budget reconciliation, pharmaceutical counterfeiting, importation S Con Res 83, Budget resolution, non-interference HR 6134, Ryan White Care Act, appropriations S 2339, Ryan White Care Act, appropriations

S 109, Pharmaceutical Market Access Act of 2005, pharmaceutical counterfeiting, importation S 334, Pharmaceutical Market Access and Drug Safety Act of 2005, pharmaceutical counterfeiting, importation, patent issues HR 3010, Department of Labor, Health and Human Service, and Education, and Related Agencies Appropriations Act, 2006, access to prescription drugs HR 3971, Social Services Emergency Relief and Recovery Act of 2005, access to prescription drugs HR 5993, Authorized Generics Prohibition, authorized generics S 3695, Authorized Generics Prohibition, authorized generics HR 4157, Better Health Information System Act, health information technology S 2300, Lower PRICED Drug Act, generic drug access, legislation on pediatric exclusivity, citizens petitions HR 6134, Ryan White Care Act, reauthorization S 2339, Ryan White Care Act, reauthorization HR 5975, Prescription Drug Comparative Effectiveness Act, drug prescriptions S 1355, Better Healthcare Through Information Technology Act, health information technology HR 6289, Personalized Health Information Act of 2006, health information technology HR 328, Pharmaceutical Market Access Act of 2005, pharmaceutical counterfeiting, importation HR 700, Pharmaceutical Market Access and Drug Safety Act of 2005, pharmaceutical counterfeiting, importation, patent issues

S 109, Pharmaceutical Market Access Act of 2005, pharmaceutical counterfeiting, importation S 334, Pharmaceutical Market Access and Drug Safety Act of 2005, pharmaceutical counterfeiting, importation, patent issues HR 3010, Department of Labor, Health and Human Service, and Education, and Related Agencies Appropriations Act, 2006, access to prescription drugs HR 3971, Social Services Emergency Relief and Recovery Act of 2005, access to prescription drugs HR 5993, Authorized Generics Prohibition, authorized generics S 3695, Authorized Generics Prohibition, authorized generics HR 4157, Better Health Information System Act, health information technology S 2300, Lower PRICED Drug Act, generic drug access, legislation on pediatric exclusivity, citizens petitions HR 6134, Ryan White Care Act, reauthorization S 2339, Ryan White Care Act, reauthorization HR 5975, Prescription Drug Comparative Effectiveness Act, drug prescriptions S 1355, Better Healthcare Through Information Technology Act, health information technology HR 6289, Personalized Health Information Act of 2006, health information technology HR 328, Pharmaceutical Market Access Act of 2005, pharmaceutical counterfeiting, importation HR 700, Pharmaceutical Market Access and Drug Safety Act of 2005, pharmaceutical counterfeiting, importation, patent issues

HR 700, Pharmaceutical Market Access and Drug Safety Act of 2005, pharmaceutical counterfeiting, importation, patent issues HR 870, The PhRMA Research and Manufacturers Accountability (PhRMA) Act, drug safety S 109, Pharmaceutical Market Access Act of 2005, pharmaceutical counterfeiting, importation S 334, Pharmaceutical Market Access and Drug Safety Act of 2005, pharmaceutical counterfeiting, importation, patent issues S 470, The Fair Access to Clinical Trials ("FACT") Act of 2005, drug safety S 930, Food and Drug Administration Safety Act of 2005, drug safety HR 5156, Counterfeit Drug Prevention Act, pharmaceutical counterfeiting S 3834, Online Pharmacy Consumer Protection Act of 2006, drug safety HR 2300, Lower PRICED Drugs Act, legislation on pediatric exclusivity, citizens petitions HR 4157, Better Health Information System Act, health information technology HR 5975, Prescription Drug Effectiveness Act, drug prescriptions S 2699, Neglected Diseases Elimination Act, promote R&D HR 2090, The Food and Drug Administration Improvement Act of 2005, drug safety HR 3196, The Fair Access to Clinical Trials ("RACT") Act of 2005, drug safety HR 328, Pharmaceutical Market Access Act of 2005, pharmaceutical counterfeiting, importation, drug safety

HR 700, Pharmaceutical Market Access and Drug Safety Act of 2005, pharmaceutical counterfeiting, importation, patent issues HR 870, The PhRMA Research and Manufacturers Accountability (PhRMA) Act, drug safety S 109, Pharmaceutical Market Access Act of 2005, pharmaceutical counterfeiting, importation S 334, Pharmaceutical Market Access and Drug Safety Act of 2005, pharmaceutical counterfeiting, importation, patent issues S 470, The Fair Access to Clinical Trials ("FACT") Act of 2005, drug safety S 930, Food and Drug Administration Safety Act of 2005, drug safety HR 5156, Counterfeit Drug Prevention Act, pharmaceutical counterfeiting S 3834, Online Pharmacy Consumer Protection Act of 2006, drug safety HR 2300, Lower PRICED Drugs Act, legislation on pediatric exclusivity, citizens petitions HR 4157, Better Health Information System Act, health information technology HR 5975, Prescription Drug Effectiveness Act, drug prescriptions S 2699, Neglected Diseases Elimination Act, promote R&D HR 2090, The Food and Drug Administration Improvement Act of 2005, drug safety HR 3196, The Fair Access to Clinical Trials ("RACT") Act of 2005, drug safety HR 328, Pharmaceutical Market Access Act of 2005, pharmaceutical counterfeiting, importation, drug safety